The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI 456906), which is ...

Japanese drugmaker Eisai has received approval in Thailand for Urece (dotinurad), a treatment for gout and hyperuricemia.

US antivirals specialist Gilead Sciences has released additional data from its pivotal Phase III PURPOSE 2 trial providing an ...

With its recent US Food and Drug Administration (FDA) approval, Eli Lilly’s Ebglyss (lebrikizumab) adds a new competitor to ...

Cardiopulmonary diseases specialist Liquidia saw an 11% rise in its stock after the US Supreme Court denied United ...

Novo Nordisk (NOV: N) has reached a settlement with Mylan Pharmaceuticals, part of Viatris (Nasdaq: VTRS), concluding a US ...

US clinical-stage biotech OnKure Therapeutics has announced the completion of its previously announced merger with Reneo ...

ViiV Healthcare, a GSK-majority-owned HIV specialist, has committed to making at least two million doses of its long-acting ...

Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical companies, including Eli Lilly, and pharmacy ...

Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including ...

Orum Therapeutics, specializing in degrader-antibody conjugates, has filed for a $67 million IPO on South Korea's Kosdaq. The ...

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...